Based on these studies, it can be speculated that, during EG in leukemia, overexpression of HOXA10 leads to sustained activation of TRIAD1, which favors a suppressed EG state, thus identifying one factor that may cause neutropenia in leukemia patients and make them more susceptible to infections (Figure 1). Here, HOXA10 is linked to leukemia.